Literature DB >> 18632988

YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5.

Carmen C Sucharov1, Karen Dockstader, Timothy A McKinsey.   

Abstract

YY1 is a transcription factor that can repress or activate the transcription of a variety of genes. Here, we show that the function of YY1 as a repressor in cardiac myocytes is tightly dependent on its ability to interact with histone deacetylase 5 (HDAC5). YY1 interacts with HDAC5, and overexpression of YY1 prevents HDAC5 nuclear export in response to hypertrophic stimuli and the increase in cell size and re-expression of fetal genes that accompany pathological cardiac hypertrophy. Knockdown of YY1 results in up-regulation of all genes present during fetal development and increases the cell size of neonatal cardiac myocytes. Moreover, overexpression of a YY1 deletion construct that does not interact with HDAC5 results in transcription activation, suggesting that HDAC5 is necessary for YY1 function as a transcription repressor. In support of this relationship, we show that knockdown of HDAC5 results in transcription activation by YY1. Finally, we show that YY1 interaction with HDAC5 is dependent on the HDAC5 phosphorylation domain and that overexpression of YY1 reduces HDAC5 phosphorylation in response to hypertrophic stimuli. Our results strongly suggest that YY1 functions as an antihypertrophic factor by preventing HDAC5 nuclear export and that up-regulation of YY1 in human heart failure may be a protective mechanism against pathological hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632988      PMCID: PMC2555926          DOI: 10.1091/mbc.e07-12-1217

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  30 in total

Review 1.  Transcriptional repression: the long and the short of it.

Authors:  A J Courey; S Jia
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

Review 2.  Division of labor in polycomb group repression.

Authors:  Stuart S Levine; Ian F G King; Robert E Kingston
Journal:  Trends Biochem Sci       Date:  2004-09       Impact factor: 13.807

3.  Transcription factor YY1 functions as a PcG protein in vivo.

Authors:  Lakshmi Atchison; Ayesha Ghias; Frank Wilkinson; Nancy Bonini; Michael L Atchison
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

4.  Regulation of transcription factor YY1 by acetylation and deacetylation.

Authors:  Y L Yao; W M Yang; E Seto
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes.

Authors:  M Patten; W E Hartogensis; C S Long
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

6.  IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes.

Authors:  M Patten; W Wang; S Aminololama-Shakeri; M Burson; C S Long
Journal:  J Mol Cell Cardiol       Date:  2000-07       Impact factor: 5.000

7.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

8.  Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter.

Authors:  Carmen C Sucharov; Peter Mariner; Carlin Long; Michael Bristow; Leslie Leinwand
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

9.  Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Authors:  Rick B Vega; Brooke C Harrison; Eric Meadows; Charles R Roberts; Philip J Papst; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype.

Authors:  W T Abraham; E M Gilbert; B D Lowes; W A Minobe; P Larrabee; R L Roden; D Dutcher; J Sederberg; J A Lindenfeld; E E Wolfel; S F Shakar; D Ferguson; K Volkman; J V Linseman; R A Quaife; A D Robertson; M R Bristow
Journal:  Mol Med       Date:  2002-11       Impact factor: 6.354

View more
  33 in total

1.  Sex differences in cardiomyocyte connexin43 expression.

Authors:  Brian L Stauffer; Rebecca D Sobus; Carmen C Sucharov
Journal:  J Cardiovasc Pharmacol       Date:  2011-07       Impact factor: 3.105

2.  Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner.

Authors:  Brian L Stauffer; Karen Dockstader; Gloria Russell; Jamie Hijmans; Lisa Walker; Mackenzie Cecil; Kimberly Demos-Davies; Allen Medway; Timothy A McKinsey; Carmen C Sucharov
Journal:  Biochem Biophys Res Commun       Date:  2015-04-29       Impact factor: 3.575

3.  AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation.

Authors:  Mark Y Jeong; John S Walker; R Dale Brown; Russell L Moore; Charles S Vinson; Wilson S Colucci; Carlin S Long
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

4.  β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5.

Authors:  Carmen C Sucharov; Karen Dockstader; Karin Nunley; Timothy A McKinsey; Michael Bristow
Journal:  J Card Fail       Date:  2011-04-22       Impact factor: 5.712

5.  Exosomes from pediatric dilated cardiomyopathy patients modulate a pathological response in cardiomyocytes.

Authors:  Xuan Jiang; Juliana Sucharov; Brian L Stauffer; Shelley D Miyamoto; Carmen C Sucharov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

6.  Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression.

Authors:  Chiara Angiolilli; Aleksander M Grabiec; Bradley S Ferguson; Caroline Ospelt; Beatriz Malvar Fernandez; Inge E van Es; Lisa G M van Baarsen; Steffen Gay; Timothy A McKinsey; Paul P Tak; Dominique L Baeten; Kris A Reedquist
Journal:  Ann Rheum Dis       Date:  2014-12-01       Impact factor: 19.103

7.  Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.

Authors:  Aibin He; Sek Won Kong; Qing Ma; William T Pu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

8.  Yin-Yang 1, a new player in early heart development.

Authors:  Yuka Morikawa; John Leach; James F Martin
Journal:  Circ Res       Date:  2013-03-15       Impact factor: 17.367

9.  Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.

Authors:  Shelley D Miyamoto; Brian L Stauffer; Stephanie Nakano; Rebecca Sobus; Karin Nunley; Penny Nelson; Carmen C Sucharov
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

Review 10.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.